SEC Filing Summary: ChromaDex Corporation (8-K)
Business Context and Reporting Period
This Form 8-K Current Report, filed on August 30, 2012, covers events occurring on August 28, 2012. The registrant is ChromaDex Corporation, a Delaware corporation headquartered in Irvine, California. The filing details the final voting results from the Company's annual meeting of stockholders held on August 28, 2012. Note: The input metadata references "Niagen Bioscience, Inc.," but the filing text explicitly identifies the registrant as ChromaDex Corporation.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report is limited to corporate governance voting results and does not contain financial performance data.
Material Changes and Voting Results
The filing reports the following outcomes from the annual meeting:
- Election of Directors: All nine nominees were elected. Votes ranged from approximately 55.0 million to 55.2 million "For" votes, with significant broker non-votes (18,431,905) recorded for all candidates.
- Appointment of Auditors: Stockholders ratified the appointment of McGladrey, LLP as the independent registered public accounting firm for the fiscal year ending December 29, 2012. The proposal received 72,834,113 "For" votes versus 724,986 "Against" votes.
- Executive Compensation (Say-on-Pay): Stockholders approved the compensation of named executive officers on an advisory basis. The proposal received 50,702,791 "For" votes, 393,842 "Against" votes, and 4,225,609 "Abstain" votes.
- Frequency of Say-on-Pay Votes: Stockholders recommended conducting future advisory votes on executive compensation every two years. This option received 36,865,125 votes, compared to 8,071,250 for one year and 6,222,400 for three years.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for future guidance, management outlook, specific risks, contingencies, or unusual items. The document serves solely to disclose the results of the shareholder vote.
Key Facts for Investor Verification
- Verify the correct registrant name is ChromaDex Corporation, not Niagen Bioscience, Inc.
- Confirm the ratification of McGladrey, LLP as the independent auditor for the fiscal year ending December 29, 2012.
- Note the high volume of broker non-votes (18,431,905) on director elections and the say-on-pay proposal.
- Observe that stockholders selected a two-year frequency for future executive compensation advisory votes.